Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 11-2024 | 08-2024 | 05-2024 | 02-2024 | 11-2023 | |
| Sales | 1,636 | 1,807 | 1,118 | 1,017 | 1,567 |
| Cost of Goods | 1,199 | 1,518 | 1,095 | 1,166 | 1,242 |
| Gross Profit | 437 | 289 | 23 | -149 | 325 |
| Operating Expenses | 1,629 | 2,175 | 1,645 | 2,017 | 2,175 |
| Operating Income | -993 | -1,368 | -1,527 | -2,000 | -1,608 |
| Other Income | 40 | 56 | 113 | 86 | 109 |
| Pre-tax Income | -953 | -1,312 | -1,414 | -1,914 | -1,499 |
| Income Tax | -3 | 4 | 7 | 4 | 8 |
| Net Income Continuous | -950 | -1,316 | -1,421 | -1,918 | -1,507 |
| Net Income | $-950 | $-1,316 | $-1,421 | $-1,918 | $-1,507 |
| EPS Basic Total Ops | -0.06 | -0.63 | -0.68 | -0.88 | -0.72 |
| EPS Basic Continuous Ops | -0.44 | -0.63 | -0.68 | -0.91 | -0.72 |
| EPS Diluted Total Ops | -0.06 | -0.63 | -0.68 | -0.88 | -0.72 |
| EPS Diluted Continuous Ops | -0.44 | -0.63 | -0.68 | -0.91 | -0.72 |
| EPS Diluted Before Non-Recurring Items | -0.48 | -0.64 | -0.72 | N/A | N/A |
| EBITDA(a) | $-893 | $-1,271 | $-1,430 | $-1,906 | $-1,517 |